PBAC says no to pan-tumour

By Megan Brodie 3 years ago | In Products
  • 3 years ago

1 February 2021 A courageous attempt by Bayer to get its pan-tumour drug VITRAKVI (larotrectinib)…

This is subscriber-only content. Please login to continue reading.